Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
PSMA ADC
Also known as: Prostate vaccine
print preview
bookmark
share with colleague
General Information
Company
Progenics Pharmaceuticals Inc.
Description
Auristatin-conjugated human mAb against prostate-specific membrane antigen (PSMA; FOLH1; GCPII)
Molecular Target
Prostate-specific membrane antigen (PSMA) (FOLH1) (GCPII)
Mechanism of Action
Antibody-drug conjugate
Latest Stage of Development
Phase II
Indication
Prostate cancer
Partner
Seattle Genetics Inc.
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy